Alveolar Differentiation Potency of Human Distal Airway Stem Cells Is Associated with Pulmonary Pathological Conditions
Autor: | Qianwen Yu, Guangdong Chen, Yueqing Zhou, Xiaotian Dai, Ting Zhang, Wei Zuo, Tao Ren, Yujia Wang, Yi Lu, Yufen Sun, Yawen Zheng, Yingchuan Wu, Yu Ma, Yujie Cao, Qiwang Ma |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
lcsh:Internal medicine Pathology medicine.medical_specialty Article Subject Cellular differentiation Pulmonary function testing 03 medical and health sciences 0302 clinical medicine Medicine Respiratory system lcsh:RC31-1245 Molecular Biology COPD Lung Bronchiectasis business.industry Interstitial lung disease Cell Biology respiratory system medicine.disease 030104 developmental biology medicine.anatomical_structure 030228 respiratory system Clinical Study Stem cell business |
Zdroj: | Stem Cells International, Vol 2019 (2019) Stem Cells International |
ISSN: | 1687-9678 1687-966X |
Popis: | Background. This study is aimed at characterizing the human distal airway stem cells (DASCs) and assessing their therapeutic potential in patients with chronic, degenerative lung diseases. These findings will provide a comprehensive understanding for further clinical applications utilizing autologous airway stem cells as therapeutic intervention in respiratory diseases. Methods. DASCs were isolated from healthy subjects or patients diagnosed with bronchiectasis, chronic obstructive pulmonary diseases (COPD), or interstitial lung disease (ILD). Differentiation capacity, a key property of the stem cells, was studied using a novel monolayer differentiation system. The differentiated cells were evaluated for alveolar and bronchial cell marker expression, and the quantified expression level of differentiated cells was further examined for their relationship with age and pulmonary function of the subjects. Results and Conclusions. Differentiation of DASCs and tracheal stem cells (TSCs) yielded an alveolus-like structure and a tube-shaped structure, respectively, with distinct marker gene expression. Additionally, single-cell-derived clones showed diverse differentiation fates, even if the clones arise from identical or different individuals. More importantly, the alveolar differentiation potency was higher in DASCs derived from patients than from healthy people. The differentiation efficiency of DASCs also correlates with age in patients with bronchiectasis and ILD. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |